is glp-1 safe to take medications continue before surgery in patients with diabetes and obesity GLP-1 diabetes and weight-loss drug

Patients were classified into two cohorts

The trade-off is reduced potency

Historically, such behavioral complexity was viewed as a disqualifying feature for drug development, as CNS-acting agents were associated with unpredictable neuropsychiatric liability and high regulatory barriers ( 5.4 Translational lessons from abandoned appetite peptides The historical trajectory of appetite and behavioral peptides reveals a recurring pattern: early development efforts often failed due to inadequate control over exposure, insufficient combination strategies, or overly conservative interpretations of side effects

P., Rehfeld, J

For those who might consider alternatives, we will discuss other medications and treatments

The mantra for people with diabetes and without diabetes is the same: We encourage them to eat 50% of what they would normally eat without the medication, said Shannon Christen, a UCHealth registered dietitian and diabetes educator